Effect of anemia on plasma concentrations of NT-proBNP

Monte Willis, Eunice S. Lee, David G. Grenache

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Concentrations of the amino-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) are increased in the blood of patients with heart failure. Understanding the variables that influence the concentrations of NT-proBNP is required to refine its clinical use criteria. The effect of anemia on plasma concentrations of NT-proBNP was investigated. Methods: Hemoglobin and NT-proBNP were measured in blood specimens collected from 209 adult patients without heart failure or renal disease. Results: The median NT-proBNP concentration of patients with anemia was significantly higher than in those without anemia (82 vs. 232 ng/l, p < 0.0001). Anemic patients were also 3 times more likely to have an NT-proBNP concentration that exceeded age-specific cutoffs recommended by the assay manufacturer (odds ratio 3.1, 95% CI 1.7 to 5.4, p < 0.0001). Conclusions: Decreased concentrations of hemoglobin are sufficient to produce serum concentrations of NT-proBNP above diagnostic cutoffs in anemic patients without heart failure independent of gender, body mass index, glomerular filtration rate, left ventricular hypertrophy, and valve disease. The impact of this finding on the clinical use and interpretation of the test needs to be examined.

Original languageEnglish (US)
Pages (from-to)175-181
Number of pages7
JournalClinica Chimica Acta
Volume358
Issue number1-2
DOIs
StatePublished - Aug 1 2005
Externally publishedYes

Fingerprint

Anemia
Plasmas
Heart Failure
Hemoglobins
Blood
Brain Natriuretic Peptide
Left Ventricular Hypertrophy
pro-brain natriuretic peptide (1-76)
Glomerular Filtration Rate
Assays
Body Mass Index
Odds Ratio
Kidney
Serum

Keywords

  • Anemia
  • Natriuretic peptides
  • NT-proBNP

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Effect of anemia on plasma concentrations of NT-proBNP. / Willis, Monte; Lee, Eunice S.; Grenache, David G.

In: Clinica Chimica Acta, Vol. 358, No. 1-2, 01.08.2005, p. 175-181.

Research output: Contribution to journalArticle

Willis, Monte ; Lee, Eunice S. ; Grenache, David G. / Effect of anemia on plasma concentrations of NT-proBNP. In: Clinica Chimica Acta. 2005 ; Vol. 358, No. 1-2. pp. 175-181.
@article{a7b9afd99087461b88d4cfa465a01d8e,
title = "Effect of anemia on plasma concentrations of NT-proBNP",
abstract = "Background: Concentrations of the amino-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) are increased in the blood of patients with heart failure. Understanding the variables that influence the concentrations of NT-proBNP is required to refine its clinical use criteria. The effect of anemia on plasma concentrations of NT-proBNP was investigated. Methods: Hemoglobin and NT-proBNP were measured in blood specimens collected from 209 adult patients without heart failure or renal disease. Results: The median NT-proBNP concentration of patients with anemia was significantly higher than in those without anemia (82 vs. 232 ng/l, p < 0.0001). Anemic patients were also 3 times more likely to have an NT-proBNP concentration that exceeded age-specific cutoffs recommended by the assay manufacturer (odds ratio 3.1, 95{\%} CI 1.7 to 5.4, p < 0.0001). Conclusions: Decreased concentrations of hemoglobin are sufficient to produce serum concentrations of NT-proBNP above diagnostic cutoffs in anemic patients without heart failure independent of gender, body mass index, glomerular filtration rate, left ventricular hypertrophy, and valve disease. The impact of this finding on the clinical use and interpretation of the test needs to be examined.",
keywords = "Anemia, Natriuretic peptides, NT-proBNP",
author = "Monte Willis and Lee, {Eunice S.} and Grenache, {David G.}",
year = "2005",
month = "8",
day = "1",
doi = "10.1016/j.cccn.2005.03.009",
language = "English (US)",
volume = "358",
pages = "175--181",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Effect of anemia on plasma concentrations of NT-proBNP

AU - Willis, Monte

AU - Lee, Eunice S.

AU - Grenache, David G.

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Background: Concentrations of the amino-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) are increased in the blood of patients with heart failure. Understanding the variables that influence the concentrations of NT-proBNP is required to refine its clinical use criteria. The effect of anemia on plasma concentrations of NT-proBNP was investigated. Methods: Hemoglobin and NT-proBNP were measured in blood specimens collected from 209 adult patients without heart failure or renal disease. Results: The median NT-proBNP concentration of patients with anemia was significantly higher than in those without anemia (82 vs. 232 ng/l, p < 0.0001). Anemic patients were also 3 times more likely to have an NT-proBNP concentration that exceeded age-specific cutoffs recommended by the assay manufacturer (odds ratio 3.1, 95% CI 1.7 to 5.4, p < 0.0001). Conclusions: Decreased concentrations of hemoglobin are sufficient to produce serum concentrations of NT-proBNP above diagnostic cutoffs in anemic patients without heart failure independent of gender, body mass index, glomerular filtration rate, left ventricular hypertrophy, and valve disease. The impact of this finding on the clinical use and interpretation of the test needs to be examined.

AB - Background: Concentrations of the amino-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP) are increased in the blood of patients with heart failure. Understanding the variables that influence the concentrations of NT-proBNP is required to refine its clinical use criteria. The effect of anemia on plasma concentrations of NT-proBNP was investigated. Methods: Hemoglobin and NT-proBNP were measured in blood specimens collected from 209 adult patients without heart failure or renal disease. Results: The median NT-proBNP concentration of patients with anemia was significantly higher than in those without anemia (82 vs. 232 ng/l, p < 0.0001). Anemic patients were also 3 times more likely to have an NT-proBNP concentration that exceeded age-specific cutoffs recommended by the assay manufacturer (odds ratio 3.1, 95% CI 1.7 to 5.4, p < 0.0001). Conclusions: Decreased concentrations of hemoglobin are sufficient to produce serum concentrations of NT-proBNP above diagnostic cutoffs in anemic patients without heart failure independent of gender, body mass index, glomerular filtration rate, left ventricular hypertrophy, and valve disease. The impact of this finding on the clinical use and interpretation of the test needs to be examined.

KW - Anemia

KW - Natriuretic peptides

KW - NT-proBNP

UR - http://www.scopus.com/inward/record.url?scp=22044441127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22044441127&partnerID=8YFLogxK

U2 - 10.1016/j.cccn.2005.03.009

DO - 10.1016/j.cccn.2005.03.009

M3 - Article

C2 - 15878465

AN - SCOPUS:22044441127

VL - 358

SP - 175

EP - 181

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -